AI Demand Sets Marvell and Micron on Diverging Paths
As the AI build-out accelerates, Marvell and Micron report results that highlight two distinct routes to profit: cust...
Year To Date Total Market Return 2024
A snapshot of the year-to-date total market return for 2024, outlining performance drivers and practical implications for investors.
28,420 articles
He’s Single, $1,750 Month: When Social Security Early Pays Off
A 63-year-old, single worker faces the classic Social Security dilemma: claim now for $1,750 monthly or delay to 70 f...
10-Year Treasury Yield Approaching 5% Reframes SCHG
As the 10-year treasury yield approaches 5%, SCHG faces higher discount rates that could compress growth valuations. ...
Foods (TBBB) 2026 Earnings: BBB Foods Q1 Early Review
BBB Foods reports Q1 2026 results with modest revenue growth and steadier margins. This review translates the transcr...
Iran Conflict 2.0 Pushes High Mortgage Rates, Market Jitters
Renewed Iran tensions push Treasury yields higher and lift mortgage costs, threatening affordability for buyers and h...
Growth Stocks Down That Could Be Long-Term Winners
When great growth ideas stumble, the long-term case often remains intact. This piece examines two names that have fal...
Want $4,800 Annual Passive Income? 3 High-Yield Dividend Stocks
As markets shift in May 2026, a popular plan to generate $4,800 per year from $40,000 in dividend stocks faces realit...
Bridgewater Just Sold Salesforce: A Patient-Stock Debate
Bridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...
How to Replace Registered Nurse’s Salary with Dividends
As of June 2026, households pursue financial independence by targeting $7,500 a month in dividend income to replace a...
Income Ladder: What Takes to Generate $5K Monthly
Savers chasing steady monthly income must quantify capital needs across three risk levels. A July 2026 snapshot shows...
Applied Digital's Stunning Rally and the Investor Analysis
A deep dive into applied digital's stunning rally, the backlog fueling demand, and the tough questions investors must...
Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status